RxSight (RXST) Shares Outstanding (2020 - 2026)
RxSight's (RXST) quarterly Shares Outstanding (Entity) came in at $41.4 million in Q1 2026, up 1.96% YoY from $40.6 million in Q1 2025, and little changed on a QoQ basis from $41.2 million in Q4 2025.
RxSight (RXST) Shares Outstanding (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Shares Outstanding (Entity) data on file, last reported at $41.4 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 1.96% year-over-year to $41.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41.4 million (up 1.96% YoY) and the FY2025 annual result came in at $41.2 million, up 2.01% from the prior year.
- Shares Outstanding (Entity) held at $41.4 million in Q1 2026, from $41.2 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $41.4 million in Q1 2026 to a low of $27.5 million in Q1 2022.
- A 5-year average of $36.2 million and a median of $37.2 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) surged 571.37% — and 2026, when it increased 1.96%.
- Tracing RXST's Shares Outstanding (Entity) over 5 years: stood at $28.3 million in 2022, then grew by 27.84% to $36.1 million in 2023, then grew by 11.87% to $40.4 million in 2024, then rose by 2.01% to $41.2 million in 2025, then grew by 0.34% to $41.4 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $41.4 million (Q1 2026), $41.2 million (Q4 2025), and $41.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 97.60 Mn |
| 10 | RxSight | 250.81 Mn | -153.43 Mn | - | 41.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.49 Mn |
| Mar 31, 2026 | 41.31 Mn |
| Dec 31, 2025 | 40.85 Mn |
| Sep 30, 2025 | 40.97 Mn |
| Jun 30, 2025 | 40.74 Mn |
| Mar 31, 2025 | 40.51 Mn |
| Dec 31, 2024 | 38.87 Mn |
| Sep 30, 2024 | 39.79 Mn |
| Jun 30, 2024 | 38.46 Mn |
| Mar 31, 2024 | 36.84 Mn |
| Dec 31, 2023 | 34.46 Mn |
| Sep 30, 2023 | 35.66 Mn |
| Jun 30, 2023 | 34.50 Mn |
| Mar 31, 2023 | 31.64 Mn |
| Dec 31, 2022 | 27.66 Mn |
| Sep 30, 2022 | 27.67 Mn |
| Jun 30, 2022 | 27.56 Mn |
| Mar 31, 2022 | 27.43 Mn |
| Dec 31, 2021 | 13.63 Mn |
| Sep 30, 2021 | 18.73 Mn |